What is the GBA1 gene?
Lysosomal acid beta-glucosidase degrading glucosylceramide and shaping glycosphingolipid storage biomarker context.
How GBA1 affects metabolism
When GBA1-related function is shifted, the practical effect is interpreted through lipoprotein transport, triglyceride-rich particles, LDL clearance, or liver lipid handling. This does not mean the pathway is active or impaired right now; it means the gene can help prioritize what to check next.
What happens when GBA1 is altered
Altered GBA1 signal should be treated as a DNA-based tendency, not a diagnosis. 1 claim currently passes the report-use gate. The useful question is whether symptoms, labs, and lifestyle context line up with the pathway signal.
Curated SNP evidence for GBA1
These SNPs come from the approved study-level evidence model. Each claim is scored from curated study rows, then gated before it can influence pathway scoring.
Evidence-backed report connection
GBA1 currently has 1 curated SNPs, 1 claim-level scores, and 1 claims eligible for pathway scoring.
Open the sample reportrs421016GBA1 c.1448T>C / Leu483Pro1 claims · 2 study rows
enzyme activity · GG or compound-heterozygous GBA1 deficiency context
GBA1 glucocerebrosidase activity tendency
rs421016 G / GBA1 c.1448T>C / p.Leu483Pro, historically L444P, is associated with lower glucocerebrosidase activity tendency and glycosphingolipid biomarker disruption in Gaucher disease contexts.
GBA1 rs421016 G is staged as a pathogenic glucocerebrosidase allele affecting lysosomal glucosylceramide degradation and Gaucher biomarker context.
Show study evidence
Common symptoms people report
- unexpected cholesterol or triglyceride results
- family context around lipid markers
- unclear ApoB, LDL-C, HDL-C, or triglyceride patterns
Biomarkers to validate
ApoB
Shows the number of atherogenic particles more directly than total cholesterol.
LDL-C, HDL-C, and triglycerides
Gives the basic lipid pattern that DNA can help contextualize.
Lp(a) or liver enzymes when relevant
Adds context for inherited lipid risk or liver lipid handling.
Where DNA analysis helps
DNA helps decide whether GBA1 deserves attention inside the broader Lipids pathway. It is most useful when combined with biomarkers instead of used as a standalone answer.
Example interpretation
GBA1 may add context to lipoprotein transport, triglyceride-rich particles, LDL clearance, or liver lipid handling, especially when its SNP evidence lines up with other genes in the same pathway.
Suggested validation: ApoB.
What to do next
- Review the Lipids pathway result before interpreting GBA1 on its own.
- Use relevant biomarkers to confirm whether this DNA tendency is visible in current biology.
- Treat supplement or nutrition decisions as follow-up steps only after the pattern fits symptoms or labs.
Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.
Get My DNA Report